Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis.
Ruan SpiesCharlotte SchutzAmy WardAvuyonke BalfourMuki Shehu SheyMark P NicolRosie BurtonBianca SossenRobert John WilkinsonDavid A BarrGraeme MeintjesPublished in: Southern African journal of HIV medicine (2022)
Mortality at 12 weeks in participants with RR-TB was high compared to participants with RS-TB. Delays in the initiation of appropriate treatment and poorer regimen efficacy are proposed as contributors to higher mortality in hospitalised patients with HIV and RR-TB.
Keyphrases
- mycobacterium tuberculosis
- antiretroviral therapy
- cardiovascular events
- hiv positive
- hiv aids
- hiv infected
- end stage renal disease
- human immunodeficiency virus
- hiv testing
- hepatitis c virus
- risk factors
- newly diagnosed
- ejection fraction
- chronic kidney disease
- men who have sex with men
- peritoneal dialysis
- cardiovascular disease
- community acquired pneumonia
- patient reported outcomes
- gestational age
- electronic health record